The Vanguard Group 13D and 13G filings for ACADIA Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:56 pm Purchase |
2023-12-29 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
The Vanguard Group | 13,396,009 8.160% |
116,234 (+0.88%) |
Filing |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
The Vanguard Group | 13,279,775 8.200% |
964,409 (+7.83%) |
Filing |
| 2022-02-09 3:15 pm Purchase |
2021-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
The Vanguard Group | 12,315,366 7.660% |
1,709,593 (+16.12%) |
Filing |
| 2021-02-10 10:30 am Sale |
2020-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
The Vanguard Group | 10,605,773 6.670% |
-10,840 (-0.10%) |
Filing |